Minnesota could get millions from $4.25B opioid settlement
Minnesota has reached several other settlements with opioid companies over the last two and a half years that have brought the state hundreds of millions of dollars.
ST. PAUL — Minnesota could see tens of millions of dollars from a tentative $4.25 billion settlement agreement with the generic drug maker Teva for its role in the opioid addiction epidemic, Attorney General Keith Ellison’s office said this week.
While the agreement between state and local governments and the Israeli pharmaceutical company announced Tuesday, July 26, is not final, Ellison in a statement said he was encouraged by the progress.
Minnesota has reached five other settlements with opioid companies over the last two and a half years, including a settlement with Johnson & Johnson and the big three drug distributors in 2021 that brought the state $300 million.
Ellison said he will continue reviewing the terms of the agreement to ensure it’s the best deal for the state. Tuesday’s announcement is the latest major development in a series of settlements Ellison and other attorneys general are pushing to reach with drug distributors, marketers and manufacturers for their role in widespread prescription painkiller addiction in the U.S.
About 5,500 Minnesotans have died due to the opioid addiction crisis, Ellison said in past statements on settlement agreements.